logo
logo
AI + EXCLUSIVE DATA

AI tracks executive moves from sources others don't have

Our proprietary AI analyzes exclusive hiring data to find decision-makers actively evaluating solutions like yours.

10-25 executive leads daily • Direct contact info • First 90 days targeting
Start with:
Flexible Plans • $39/mo or $29/mo annual
AI + proprietary hiring database
Executive contact details included
INDUSTRY FIRST

Hillstar Bio Appoints Maude Tessier As Chief Operating Officer

May 28, 20252 months ago

Position

Chief Operating Officer

Company

Hillstar Bio

Maude Tessier
BostonTherapeuticsBiotechnologyHealth Care

Description

Hillstar Bio has announced the appointment of Maude Tessier, Ph.D., as Chief Operating Officer. This hiring aims to strengthen the leadership team and advance the company's lead program for the treatment of axial spondyloarthritis.

Company Information

Company

Hillstar Bio

Location

Boston, Massachusetts, United States

About

Hillstar Bio is a biotechnology company focused on developing next-generation precision immunology therapies for autoimmune diseases. Their approach selectively targets and depletes pathogenic immune cells while preserving healthy ones, aiming to provide durable relief and improve patient outcomes. The company's innovative methods leverage tailored discovery techniques, distinguishing them from traditional drug development. They are advancing a pipeline of therapies aimed at specific immune cell subsets for various autoimmune disorders.

FundzWatch™ Score

71
Medium Activity

Related People

Sign in to view contact details

Sign in to view contact details

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months